A case of latent autoimmune diabetes of adult with systemic lupus erythematosus
Main Article Content
http://orcid.org/0000-0001-5840-3804
Abstract
Systemic lupus erythematosus and latent diabetes mellitus are chronic systemic disorders that affect any part of the body. Both have autoimmune origins. However, their coexistence is rare. A fifty-five-year-old woman of average build presented with skin rashes at Kamshet Primary Health Centre. Her blood test was positive for antinuclear antibodies, and she was treated with hydroxychloroquine. The patient also had increased urination and blurring of vision. Her fasting blood sugar was 260 mg/dl; her HbA1c was high,12.2%, and her C-peptide level was low (1.67 ng/ml). Singly and in combination, oral antidiabetic drugs made no difference to blood sugar levels, but the insulin response was prompt. We report a case that had features of both type 1 and type 2 diabetes along with systemic lupus erythematosus.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis Rheumatol. 2014 Feb;66(2):357-68.
3. Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities, and socioeconomic impact. Nat Rev Rheumatol 2016; 12:605-20.
4. Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 2021; 17: 515-32.
5. Tian J, Zhang D, Yao X, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Annals of the Rheumatic Diseases 2023;82:351-356.
6. Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of Systemic Lupus Erythematosus in India. Lupus. 1993;2(2):115-118.
7. Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:17016.
8. Cortes S, Chambers S, Jerónimo A, Isenberg D. Diabetes mellitus complicating systemic lupus erythematosus—analysis of the UCL lupus cohort and literature review. Lupus. 2008;17(11):977–980.
9. Su K, Jia Z, Wu Y, Sun Y, Gao Q, Jiang Z, Jiang J. A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level, and systemic lupus erythematosus: Mendelian randomization study. PLoS One. 2023 May 17;18(5).
10. Etchegaray-Morales I, Mendoza-Pinto C, Munguía-Realpozo P, Solis-Poblano JC, Méndez-Martínez S, Ayón-Aguilar J, Abud-Mendoza C, García-Carrasco M, Cervera R. Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2024 Aug 1;63(8):2047-2055.
11. Lin YJ, Chien CC, Ho CH, Chen HA, Chen CY. Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: A nationwide cohort study in Taiwan. Medicine (Baltimore). 2022 Dec 23;101(51).
12. Hemminki K, Liu X, Försti A, et al. Subsequent type 2 diabetes in patients with autoimmune disease. Sci Rep. 2015; 5:13871.
13. Kuo CF, Chou IJ, Rees F, et al. Temporal relationships between systemic lupus erythematosus and comorbidities. Rheumatology (Oxford). 2019; 58:840–8.
14. Tizaoui K, Terrazzino S, Cargnin S, et al. Seminars in arthritis and rheumatism. 2021; 51:513-22.
15. Alvarez-Payares JC, Ribero D, Rodríguez L, Builes CE, Prieto C, Arango C, Gamboa JG, Alvarez-Payares C. Late Systemic Lupus Erythematosus-Associated Insulin Resistance Syndrome: A Rare Cause of De Novo Diabetes Mellitus. Case Rep Med. 2022 Oct 14; 2022:4655804.